nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Expert Commentary: Gastrointestinally Active Lipid-Lowering Drug Safety
|
Toth, Peter P. |
|
2007 |
99 |
6S1 |
p. S56-S58 3 p. |
artikel |
2 |
Expert Commentary: Niacin Safety
|
Brown, B. Greg |
|
2007 |
99 |
6S1 |
p. S32-S34 3 p. |
artikel |
3 |
Expert Commentary: The Safety of Fibrates in Lipid-Lowering Therapy
|
Brown, W. Virgil |
|
2007 |
99 |
6S1 |
p. S19-S21 3 p. |
artikel |
4 |
Expert Opinion: Omega-3 Fatty Acids and Bleeding—Cause for Concern?
|
Harris, William S. |
|
2007 |
99 |
6S1 |
p. S44-S46 3 p. |
artikel |
5 |
Faculty Disclosures
|
|
|
2007 |
99 |
6S1 |
p. vi-vii nvt p. |
artikel |
6 |
Faculty List
|
|
|
2007 |
99 |
6S1 |
p. v- 1 p. |
artikel |
7 |
Introduction
|
McKenney, James M. |
|
2007 |
99 |
6S1 |
p. S1-S2 2 p. |
artikel |
8 |
Safety Considerations with Fibrate Therapy
|
Davidson, Michael H. |
|
2007 |
99 |
6S1 |
p. S3-S18 16 p. |
artikel |
9 |
Safety Considerations with Gastrointestinally Active Lipid-Lowering Drugs
|
Jacobson, Terry A. |
|
2007 |
99 |
6S1 |
p. S47-S55 9 p. |
artikel |
10 |
Safety Considerations with Niacin Therapy
|
Guyton, John R. |
|
2007 |
99 |
6S1 |
p. S22-S31 10 p. |
artikel |
11 |
Safety Considerations with Omega-3 Fatty Acid Therapy
|
Bays, Harold E. |
|
2007 |
99 |
6S1 |
p. S35-S43 9 p. |
artikel |
12 |
Title page/Sponsorship
|
|
|
2007 |
99 |
6S1 |
p. i- 1 p. |
artikel |